Estrogen receptor modulators

Details for Australian Patent Application No. 2003237084 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

Priority application(s): 60/375,237 24.04.02 US

18 December 2003 Application Open to Public Inspection

Published as AU-B-2003237084

20 November 2008 Application Accepted

Published as AU-B-2003237084

27 November 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 12 Nov 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

26 March 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 12 Nov 2008

26 March 2009 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.